NYMC Faculty Publications
No Histologic Evidence of Foetal Cardiotoxicity Following Exposure to Maternal Hydroxychloroquine
Journal Title
Clinical and Experimental Rheumatology
First Page
857
Last Page
859
Document Type
Article
Publication Date
9-1-2017
Department
Pediatrics
Abstract
It is currently recommended that hydroxychloroquine (HCQ) be maintained during pregnancy in patients with systemic lupus erythematosus. Recent data suggest that this Toll-like receptor inhibitor may also reduce the recurrence rate of anti-SSA/Ro associated congenital heart block (CHB). This case report describes a unique situation in which a CHB-afflicted, HCQ-exposed pregnancy was electively terminated. The heart did not reveal any characteristic features of cardiotoxicity, providing further evidence supporting the safety of foetal exposure to HCQ.
Recommended Citation
Friedman, D., Lovig, L., Halushka, M., Clancy, R. M., Izmirly, P. M., & Buyon, J. P. (2017). No Histologic Evidence of Foetal Cardiotoxicity Following Exposure to Maternal Hydroxychloroquine. Clinical and Experimental Rheumatology, 35 (5), 857-859. Retrieved from https://touroscholar.touro.edu/nymc_fac_pubs/230
Publisher's Statement
Originally published in Clinical and Experimental Rheumatology, 35 (5), 857-859. The original material can be found here.
